The Risk of QTc Prolongation in Non-Diabetic and Diabetic Patients Taking Tyrosine Kinase Inhibitors (TKIs)- A Patient Safety Project at a Private Oncology Practice-Reference-Cited by-同舟云学术

The Risk of QTc Prolongation in Non-Diabetic and Diabetic Patients Taking Tyrosine Kinase Inhibitors (TKIs)- A Patient Safety Project at a Private Oncology Practice

Published:2021-11-02 Issue:6 Volume:11 Page:799-807
ISSN:2000-9666
Container-title:Journal of Community Hospital Internal Medicine Perspectives
language:en
Short-container-title:Journal of Community Hospital Internal Medicine Perspectives

Author:

Lu Zhongju¹,Luu Ying²^ORCID,Ip Jack²,Husain Imran²,Lu Michael³,Kim Chang-Kyung¹,Yang Peng¹,Chu David⁴,Lin Richard³,Cohen Ira³,Kaell Alan²^ORCID

Affiliation:

1. Department of Medicine, Stony Brook University, Stony Brook, NY, USA

2. Department of Internal Medicine, John T. Mather Memorial Hospital, Port Jefferson, NY, USA

3. Department of Physiology and Biophysics, Stony Brook University, Stony Brook, NY, USA

4. New York Cancer & Blood Specialists, East Setauket, NY, USA

Funder

National Institutes of Health

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/20009666.2021.1978652

Reference35 articles.

1. Prevention, C.f.D.C.a. National Diabetes Statistics Report, 2017. Atlanta, GA Centers for Disease Control and Prevention, US Department of Health and Human Services. 2017.

2. Mortality and Predictors of Mortality in a Cohort of Brazilian Type 2 Diabetic Patients

3. Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus

4. Acquired long QT syndrome and phosphoinositide 3-kinase

5. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gefitinib Increases the Incidence of QT Prolongation in Patients with Non-Small Cell Lung Cancer;International Heart Journal;2023-05-31

2. The association of QTc prolongation with cardiovascular events in cancer patients taking tyrosine kinase inhibitors (TKIs);Cardio-Oncology;2023-05-19